Newsletter | October 16, 2024

10.16.24 -- Why AstraZeneca And AbbVie Are Intensifying Processes

SPONSOR

Empowering Your Quest to Reshape the Future with mRNA Manufacturing

From state-of-the-art purification to high-quality raw materials – we’re supporting you on your way to breakthrough mRNA vaccines and therapeutics. – Read our technical article on Manufacturing Strategies for mRNA Vaccines and Therapeutics now!

FOCUS ON DOWNSTREAM MANUFACTURING

Why AstraZeneca And AbbVie Are Intensifying Processes

In this segment of the Bioprocess Online Live event Bioprocess Intensification In The Real World, our speakers share the motivation for continued process intensification in their respective organizations.

Solving Bispecific Antibody Heavy-Light Chain Mispairing

Explore how the bYlok bispecific pairing technology can be used to solve heavy-light chain mispairing in bispecific antibodies and how it compares with alternative scaffolds.

Eliminate Downstream Bottlenecks In Antibody-Based Therapies

Organizations seeking greater efficiency within their downstream purification processes are well-served in considering a single-use, membrane-based solution in lieu of resin-based purification columns.

Advantages Of Automated Sample Preparation

Automated sample purification kits enable consistency while reducing plastic waste and enabling cost-saving for your facility, reducing the overall price per sample.

mAb Purification Process Development Using Mixed-Mode Resins

Compare two multimodal resin alternatives used for the polishing step post–protein A capture with data that demonstrates the behavior of multiple mAbs.

Increased Productivity At The mAb Capture Step

Biopharma company enjoys reductions in overall cost and upfront investment in their consumables with no change to the quality of the resulting product with a multicolumn format.

SPONSOR

Webinar: How to Plan for Trouble-Free Filter Validation

Join Cytiva as they discuss regulatory expectations for process-specific filter validation in drug products requiring sterile filtration. Learn best practices for conducting process-specific filter studies, essential for marketing authorization applications such as NDA and MMA. Participants will learn about timing for validation, laboratory requirements, and strategies for successful implementation across various drug types, including monoclonal antibodies and advanced therapy medicinal products. Click here to learn more.

DOWNSTREAM MANUFACTURING SOLUTIONS

Chromatography Modeling Software Solution - Cytiva

Secure Connections In Cryogenic Applications - Nordson MEDICAL

Protein L Mix-N-Go ELISA Kits - Cygnus Technologies Inc.

Connect With Bioprocess Online: